Latest Period
n/a
Security Snapshot
UNICYCIVE THERAPEUTICS INC - COM NEW Institutional Ownership
CUSIP: 90466Y202
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
Shares (Excl. Options)
Price
$7.71
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM NEW
- SEC-reported price per share
- $7.71
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- 90466Y202 - UNICYCIVE THERAPEUTICS INC - COM NEW is tracked under CUSIP 90466Y202.
- Latest finished 13F holder period is not available.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 3 to 1 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $6,416,904 to $167,908.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
90466Y202
Latest holder period
n/a
13F holders
13D/G owners
0
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 90466Y202:
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
n/a
Rows shown
1-2 of 2